← Back to Search

Behavioral Intervention

Telemedicine-Based Therapy for Substance Abuse

N/A

Waitlist Available

Led By Allison Lin, MD

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Outpatient care at Michigan Medicine in past year

Be older than 18 years old

Must not have

Conditions that preclude informed consent (e.g., acute psychosis, cognitive deficits) or understanding of assessment or program content

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing the feasibility and acceptability of motivational interviewing and psychosocial intervention programs delivered via telehealth to help improve substance use and other related outcomes in patients with substance use disorders.

Who is the study for?

This trial is for individuals who have used substances on average twice a week over the past month, have been outpatient at Michigan Medicine in the last year, and own a device like a smartphone with internet. People can't join if they can't consent (like having acute psychosis), had severe alcohol withdrawal before, or don't speak English.

What is being tested?

The study tests motivational interviewing and psychosocial interventions delivered through telehealth to help patients with Substance Use Disorder (SUD). It aims to refine these programs for better feasibility and acceptability among 50 participants.

What are the potential side effects?

Since this trial involves psychological therapy via telemedicine rather than medication, traditional physical side effects are not expected. However, discussing substance use may cause emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have received outpatient care at Michigan Medicine in the last year.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am mentally capable of understanding and consenting to participate.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Feasibility of the intervention (engagement)

Tele-Tx Intervention acceptability

Other study objectives

Change in Alcohol Consumption

Change in frequency of substance use as reported on the Timeline Follow-Back (TLFB)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: TeletxExperimental Treatment1 Intervention

The evidence-based manualized psychosocial programs that will be delivered via telehealth are adaptations of cognitive behavioral therapy, motivational interviewing, and other psychosocial interventions to enhance initial and ongoing treatment engagement. TeleTx consists of up to 8 \~30-50 minute psychosocial sessions delivered via phone or videoconference platform (e.g. Zoom etc).

0 / 2Eligibility criteria met